reference/34356589

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34356589

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	2021
issn	2092-6413
issueIdentifier	11
pageRange	2007-2021
publicationName	Experimental & Molecular Medicine
startingPage	2007
bibliographicCitation	Zhou J, Feng J, Wu Y, Dai HQ, Zhu GZ, Chen PH, Wang LM, Lu G, Liao XW, Lu PZ, Su WJ, Hooi SC, Ye XP, Shen HM, Peng T, Lu GD. Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy. Exp Mol Med. 2022 Nov;54(11):2007–21. PMID: 36385558; PMCID: PMC9723179.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db6c5bfda85398b4861a5651c467417d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e1f669dfcee7b466901a563efed5f1e8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1648e785ce0979f695c73c9aa40acbc5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3c6fd896d03123f0aeb3388338df36e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4852eb53dff86a4736fbc4c7b9df7b33 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d3828e8d98021b12883d641d43c3e92b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dea2c61bd4705b1570f06ca9447bee48 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_618abaf72f497089b6ee336c9cf3ec08 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62312898eb7bd1f365fc98b0403f1f39 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6056-3196 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1942b1e88d87f86f35222da458e94046 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1528a8a4992d9ac5e9e65b7421dab151 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bbea8eeeaa424c6382dfb69b24ea7369 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2da5315aa349c9521fca01a2f26589e8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eba80bed3be2507ec58f1b5c445891b6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42a0d8a363aa08059c6404323c758223
date	2022-11-16^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/36385558 https://pubmed.ncbi.nlm.nih.gov/PMC9723179 https://doi.org/10.1038/s12276-022-00878-x
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21152 https://portal.issn.org/resource/ISSN/2092-6413
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy
discusses	http://id.nlm.nih.gov/mesh/M0014833 http://id.nlm.nih.gov/mesh/M0009339 http://id.nlm.nih.gov/mesh/M0446095 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D008113Q000473 http://id.nlm.nih.gov/mesh/D006528Q000188 http://id.nlm.nih.gov/mesh/D006528Q000473 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D016461 http://id.nlm.nih.gov/mesh/D008113Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D063306 http://id.nlm.nih.gov/mesh/D009536Q000494 http://id.nlm.nih.gov/mesh/D000077157Q000627 http://id.nlm.nih.gov/mesh/D000077157Q000494 http://id.nlm.nih.gov/mesh/D005947 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_76759e18098ee3dda1e9a69c87e6fb72 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9823820 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0e28e7c63a1814d28acc5cb179f2717f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24812758 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54682830 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703

Showing number of triples: 1 to 64 of 64.